Christopher van Dyck MD
Professor of Psychiatry, Neurology, and Neurobiology; Director, Alzheimer's Disease Research Unit
Departments & OrganizationsYale Combined Program in the Biological and Biomedical Sciences (BBS): NeuroscienceInterdepartmental Neuroscience ProgramNeurobiologyNeurologyDorothy Adler Geriatric Assessment CenterPsychiatry: Alzheimer's Disease Research Unit
| Aging & Geriatric Psychiatry, Division of
Christopher H. van Dyck, MD, is Professor of Psychiatry, Neurology, and Neurobiology, and Director of the Alzheimer's Disease
Research Unit at Yale. His research interests include therapeutic, neuroimaging
and genetic studies of Alzheimer's disease (AD) and healthy cognitive aging. Dr.
van Dyck is very active in AD therapeutic research. Since 1992 he has
participated in 70+ multicenter clinical trials for AD and MCI and has authored
several of the trial publications. He serves on the Steering Committees of the NIA Alzheimer's Disease Cooperative Study (ADCS) and Alzheimer's Disease Neuroimaging Initiative (ADNI). Dr. van Dyck’s other
significant scholarly contributions include dopamine transporter imaging in
healthy aging and the apolipoprotein E e4 Phenotype
of AD. In 2005 he received the "Compassion and Cure" Award from the Alzheimer's Association.
- B.A., Yale University
- M.D., Northwestern University
- Mitsis EM, Cosgrove KP, Staley JK, Bois F, Frohlich EB, Tamagnan GD, Estok KM, Seibyl JP, van Dyck CH. Age-related decline in nicotinic receptor availability with [123I]5-IA-85380 SPECT. Neurobiol Aging 2009;30(9):1490-7.
Latest Honor and Recognition
- Best Doctors in New York (Top 2%), as Featured in New York Magazine
, Castle Connolly